STAT | Reporting from the frontiers of health and medicine Follow STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more The U.S. is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing deals for Chinese drugs https://www.statnews.com/pharmalot/2026/09/18/rules-for-china-licensing-deals-making-drugs-in-space/ statnews.com
